| Financial Year |
March 31 2023 |
| Monetary Funds |
2,450,545,219.37 |
| Held-for-trading Financial Assets |
401,772,054.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,700,345,318.04 |
| Advances to Suppliers |
159,625,226.93 |
| Other Receivables |
36,516,638.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,942,249,821.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,000,000.00 |
| Other Current Assets |
54,269,986.59 |
| Total Current Assets |
7,442,019,261.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,807,348.15 |
| Long-term Equity Investment |
337,071,328.17 |
| Investment Properties |
43,254,981.98 |
| Fixed Assetes |
2,985,029,084.51 |
| Under-construction Projects |
475,077,258.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,506,488,021.79 |
| R&D expenses |
779,235,725.64 |
| Goodwill |
934,958,114.19 |
| Long-Term Deferred and Prepaid Expenses |
19,458,746.02 |
| Deferred Income Tax Assets |
113,493,596.73 |
| Other Non-Current Assets |
35,894,174.15 |
| Sub-Total of Non-Current Assets |
7,312,911,993.79 |
| Total Assets |
14,754,931,255.58 |
| Short-Term Loans |
6,826,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,113,164.50 |
| Accounts Payable |
789,592,445.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
222,835,328.65 |
| Taxes Payable |
200,298,132.48 |
| Interest Payable |
-- |
| Dividend Payable |
6,407,800.00 |
| Other payables |
1,459,698,078.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
266,666.66 |
| Other Current Liabilities |
57,203,660.71 |
| Sub-Total of Current Liabilities |
2,883,877,993.54 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
545,988.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,667,341.28 |
| Deferred Income Tax Liabilities |
155,109,432.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
753,062,838.39 |
| Total Liabilities |
3,636,940,831.93 |
| Paid-In Capital(Or Share Stock) |
1,043,154,310.00 |
| Capital Surplus |
127,140,258.03 |
| Surplus Reserve |
481,148,439.78 |
| LESS:Treasury Stock |
175,676,578.68 |
| Undistributed Profits |
8,933,316,410.40 |
| Minority Stockholder's Interest |
709,280,159.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,408,710,264.29 |
| Owner's Equity（Stockholder's Equity） |
11,117,990,423.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,754,931,255.58 |
